Serum luteinizing hormone in patients undergoing ovarian stimulation with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone and its relationship with cycle outcome.
The serum LH was determined on days 3, 6, and 8 of stimulation and on the day of hCG in 110 normogonadotropic patients undergoing controlled ovarian hyperstimulation (COH) for IVF induced with GnRH antagonists and recombinant FSH, creating three groups of patients according to Tukey's hinges (percentiles 25 and 75) for each determination. No differences were observed between the number of oocytes recovered or the fertilization, implantation, and pregnancy rates (PR) of the groups, although patients with high serum LH levels during stimulation showed significantly higher serum E2 levels on the day of hCG.
Bosch
Ernesto
E
Instituto Valenciano de Infertilidad, Valencia, Spain.
Escudero
Ernesto
E
Crespo
Juana
J
Simón
Carlos
C
Remohí
José
J
Pellicer
Antonio
A
D000293:Adolescent; D000328:Adult; D015331:Cohort Studies; D005260:Female; D043373:Follicle Stimulating Hormone, Human / Q000627:therapeutic use*; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D006801:Humans; D007247:Infertility, Female / Q000097:blood / Q000188:drug therapy; D007986:Luteinizing Hormone / Q000097:blood*; D008597:Menstrual Cycle / Q000187:drug effects / Q000502:physiology*; D010062:Ovulation Induction / Q000379:methods* / Q000706:statistics & numerical data; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000627:therapeutic use
D043373:Follicle Stimulating Hormone, Human; D011994:Recombinant Proteins; D007987:Gonadotropin-Releasing Hormone; D007986:Luteinizing Hormone